المؤلفون: Olivier J. van Not, Thijs T. Wind, Rawa K. Ismail, Arkajyoti Bhattacharya, Mathilde Jalving, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, John B. Haanen, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Rozemarijn S. van Rijn, Marion Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Willeke A. M. Blokx, Karijn P. M. Suijkerbuijk, Rudolf S. N. Fehrmann, Geke A. P. Hospers

المصدر: Cancers; Volume 15; Issue 11; Pages: 2922

مصطلحات موضوعية: advanced melanoma, immunotherapy, brain metastases, survival tree

وصف الملف: application/pdf

Relation: Cancer Immunology and Immunotherapy; https://dx.doi.org/10.3390/cancers15112922

الاتاحة: https://doi.org/10.3390/cancers15112922

المؤلفون: Melissa M. De Meza, Willeke A. M. Blokx, Johannes J. Bonenkamp, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. De Groot, John B. A. G. Haanen, Geke A. P. Hospers, Ellen Kapiteijn, Olivier J. Van Not, Djura Piersma, Rozemarijn S. Van Rijn, Marion Stevense-den Boer, Astrid A. M. Van der Veldt, Gerard Vreugdenhil, Alfonsus J. M. Van den Eertwegh, Karijn P. M. Suijkerbuijk, Michel W. J. M. Wouters

المصدر: Cancers; Volume 15; Issue 2; Pages: 409

مصطلحات موضوعية: melanoma, adjuvant therapy, targeted therapy, immune checkpoint inhibition

وصف الملف: application/pdf

Relation: Cancer Immunology and Immunotherapy; https://dx.doi.org/10.3390/cancers15020409

الاتاحة: https://doi.org/10.3390/cancers15020409

المؤلفون: Daan Jan Willem Rauwerdink, Remco van Doorn, Jos van der Hage, Alfonsus J. M. Van den Eertwegh, John B. A. G. Haanen, Maureen Aarts, Franchette Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan Willem B. De Groot, Geke A. P. Hospers, Melissa de Meza, Djura Piersma, Rozemarijn S. Van Rijn, Marion Stevense, Astrid Van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Karijn Suijkerbuijk, Monique van der Kooij, Ellen Kapiteijn

المصدر: Cancers; Volume 14; Issue 22; Pages: 5694

مصطلحات موضوعية: melanoma, immune checkpoint inhibitors, targeted therapy, survival

وصف الملف: application/pdf

Relation: Cancer Therapy; https://dx.doi.org/10.3390/cancers14225694

الاتاحة: https://doi.org/10.3390/cancers14225694

المؤلفون: Isabella A. J. van Duin, Sjoerd G. Elias, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Willeke A. M. Blokx, Paul J. van Diest, Tim Leiner, Joost J. C. Verhoeff, Rik J. Verheijden, Olivier J. van Not, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, John B. A. G. Haanen, Geke A. P. Hospers, Anna M. Kamphuis, Djura Piersma, Rozemarijn S. van Rijn, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Marion A. M. Stevense‐den Boer, Marye J. Boers‐Sonderen, Ellen Kapiteijn, Karijn P. M. Suijkerbuijk

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Radiology & Nuclear Medicine

المصدر: van Duin, I A J, Elias, S G, van den Eertwegh, A J M, de Groot, J W B, Blokx, W A M, van Diest, P J, Leiner, T, Verhoeff, J J C, Verheijden, R J, van Not, O J, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Haanen, J B A G, Hospers, G A P, Kamphuis, A M, Piersma, D, van Rijn, R S, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Stevense-den Boer, M A M, Boers-Sonderen, M J, Kapiteijn, E & Suijkerbuijk, K P M 2023, ' Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma ', International Journal of Cancer, vol. 152, no. 12, pp. 2493-2502 . https://doi.org/10.1002/ijc.34479
International Journal of Cancer, 152(12), 2493-2502. Wiley
International Journal of Cancer, 152(12), 2493-2502. Wiley-Liss Inc.

مصطلحات موضوعية: Mitogen-Activated Protein Kinase Kinases, Cancer Research, Oncology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Proto-Oncogene Proteins B-raf/genetics, BRAF(/MEK) inhibition, melanoma, SURVIVAL, Humans, immune checkpoint inhibition, immunotherapy, prognosis, Retrospective Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6899fe47da203e306ee373387a5e2107
https://doi.org/10.1002/ijc.34479

المؤلفون: Jesper van Breeschoten, Alfonsus J. M. van den Eertwegh, Liesbeth C. de Wreede, Doranne L. Hilarius, Erik W. van Zwet, John B. Haanen, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Jan Willem B. de Groot, Geke A. P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Marion A. M. Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Marye J. Boers-Sonderen, Karijn P. M. Suijkerbuijk, Michel W. J. M. Wouters

المصدر: Cancers; Volume 13; Issue 20; Pages: 5077

مصطلحات موضوعية: advanced melanoma, survival, center variation

وصف الملف: application/pdf

Relation: https://dx.doi.org/10.3390/cancers13205077

الاتاحة: https://doi.org/10.3390/cancers13205077

المؤلفون: Nienke A. de Glas, Esther Bastiaannet, Frederiek van den Bos, Simon P. Mooijaart, Astrid A. M. van der Veldt, Karlijn P. M. Suijkerbuijk, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Alfonsus J. M. van den Eertwegh, Jan-Willem B. de Groot, John B. A. G. Haanen, Geke A. P. Hospers, Hilde Jalving, Djura Piersma, Rozemarijn S. van Rijn, Albert J. ten Tije, Gerard Vreugdenhil, Michel W. J. M. Wouters, Johanneke E. A. Portielje, Ellen W. Kapiteijn

المصدر: Cancers; Volume 13; Issue 11; Pages: 2826

مصطلحات موضوعية: immunotherapy, melanoma, older adults, geriatric oncology, toxicity, response

وصف الملف: application/pdf

Relation: Clinical Trials of Cancer; https://dx.doi.org/10.3390/cancers13112826

الاتاحة: https://doi.org/10.3390/cancers13112826

المؤلفون: Monique K. van der Kooij, Olaf M. Dekkers, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Hans M. Westgeest, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Sofie Wilgenhof, Michel W. J. M. Wouters, John B. A. G. Haanen, Alfonsus J. M. van den Eertwegh, Ellen Kapiteijn

المصدر: Cancers, Vol 13, Iss 4639, p 4639 (2021)

مصطلحات موضوعية: sex, advanced melanoma, immunotherapy, targeted therapy, prospective nation-wide data, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Relation: https://www.mdpi.com/2072-6694/13/18/4639; https://doaj.org/toc/2072-6694; https://doaj.org/article/ac0de538cce042d19dfd6acb34ba763d

الاتاحة: https://doi.org/10.3390/cancers13184639
https://doaj.org/article/ac0de538cce042d19dfd6acb34ba763d

المؤلفون: Anne M May, Michel W J M Wouters, Ellen Kapiteijn, John B A G Haanen, Christian U Blank, Maureen J B Aarts, Rik J Verheijden, Astrid A M van der Veldt, Marye J Boers-Sonderen, Franchette W P J van den Berkmortel, Alfonsus J M van den Eertwegh, Jan Willem B de Groot, Jacobus J M van der Hoeven, Geke A P Hospers, Djura Piersma, Rozemarijn S van Rijn, Albert J ten Tije, Gerard Vreugdenhil, Michiel C T van Zeijl, Karijn P M Suijkerbuijk

المصدر: ESMO Open, Vol 5, Iss 6 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://esmoopen.bmj.com/content/5/6/e000945.full; https://doaj.org/toc/2059-7029

URL الوصول: https://doaj.org/article/e9745cefbc3341ff89aba01c2bbe198f

المؤلفون: Christian U. Blank, John B. A. G. Haanen, Doranne L. Hilarius, Michel W. J. M. Wouters, Willeke A. M. Blokx, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Rawa K. Ismail, Geke A. P. Hospers, Jesper van Breeschoten, Alfonsus J. M. van den Eertwegh, Rozemarijn S. van Rijn, Jan Willem B. de Groot, Maureen J.B. Aarts, D Piersma, Astrid A M van der Veldt, G. Vreugdenhil, Marion A. M. Stevense-den Boer, Marye Boers-Sonderen, Karijn P M Suijkerbuijk, Olivier J. van Not, Melissa M. De Meza

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D)

المصدر: International Journal of Cancer, 150(5), 816-824. Wiley
van Not, O J, van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, de Meza, M M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Blokx, W A M, Suijkerbuijk, K P M & Wouters, M W J M 2022, ' The unfavorable effects of COVID-19 on Dutch advanced melanoma care ', International Journal of Cancer, vol. 150, no. 5, pp. 816-824 . https://doi.org/10.1002/ijc.33833
International Journal of Cancer, 150, 816-824
International Journal of Cancer, 150, 5, pp. 816-824
International Journal of Cancer, 150(5), 816-824. Wiley-Liss Inc.
International Journal of Cancer, 150(5), 816-824. WILEY
International Journal of Cancer

مصطلحات موضوعية: Adult, Male, advanced melanoma, Cancer Research, Pediatrics, medicine.medical_specialty, Skin Neoplasms, Coronavirus disease 2019 (COVID-19), IMPACT, nationwide registry, Medical care, Systemic therapy, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], systemic therapy, SDG 3 - Good Health and Well-being, COVID‐19, Humans, Medicine, Stage IIIC, Cancer Therapy and Prevention, Melanoma, Aged, Netherlands, Advanced melanoma, Aged, 80 and over, Control period, Performance status, SARS-CoV-2, business.industry, COVID-19, Middle Aged, medicine.disease, clinical outcomes, Oncology, Female, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6999d1436b905ac42aa992a91b031b28
https://hdl.handle.net/2066/244556

المؤلفون: Marscha S. Holleman, Simone A. Huygens, Maiwenn J. Al, Malou C. P. Kuppen, Hans M. Westgeest, Alfonsus C. M. van den Bergh, Andries M. Bergman, Alfonsus J. M. van den Eertwegh, Mathijs P. Hendriks, Menuhin I. Lampe, Niven Mehra, Reindert J. A. van Moorselaar, Inge M. van Oort, Diederik M. Somford, Ronald de Wit, Agnes J. van de Wouw, Winald R. Gerritsen, Carin A. Uyl-de Groot

المساهمون: Erasmus School of Health Policy & Management, Health Technology Assessment (HTA), Medical Oncology, Internal medicine, Medical oncology, Urology, CCA - Imaging and biomarkers, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Drugs-Real World Outcomes, 9(2), 275-285. Springer International Publishing AG
Drugs – Real World Outcomes, 9. SPRINGERNATURE
Drugs-Real World Outcomes, 9, 275-285
Holleman, M S, Huygens, S A, Al, M J, Kuppen, M C P, Westgeest, H M, van den Bergh, A C M, Bergman, A M, van den Eertwegh, A J M, Hendriks, M P, Lampe, M I, Mehra, N, van Moorselaar, R J A, van Oort, I M, Somford, D M, de Wit, R, van de Wouw, A J, Gerritsen, W R & Groot, C A U 2022, ' Being Transparent About Brilliant Failures : An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer ', Drugs-Real World Outcomes, vol. 9, no. 2, pp. 275-285 . https://doi.org/10.1007/s40801-022-00294-7
Drugs-Real World Outcomes, 9, 2, pp. 275-285

مصطلحات موضوعية: ENZALUTAMIDE, PLUS PREDNISONE, CHEMOTHERAPY, MITOXANTRONE, ABIRATERONE ACETATE, DOUBLE-BLIND, SDG 3 - Good Health and Well-being, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], SIMULATION, DOCETAXEL TREATMENT, Pharmacology (medical), SURVIVAL ANALYSIS, POPULATION

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0e79a8893171c8e80aeeaea6630e50
https://hdl.handle.net/2066/251781

المؤلفون: Monique K. van der Kooij, Arjen Joosse, Karijn P. M. Suijkerbuijk, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, John B. A. G. Haanen, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Hans M. Westgeest, Michel W. J. M. Wouters, Olaf M. Dekkers, Ellen Kapiteijn

المساهمون: Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Oncology, Radiology & Nuclear Medicine

المصدر: British Journal of Cancer, 128, 5, pp. 707-710
British Journal of Cancer. SPRINGERNATURE
British Journal of Cancer
British Journal of Cancer, 128(5), 707-710. Nature Publishing Group
British Journal of Cancer. Nature Publishing Group
British Journal of Cancer, 128, 707-710

مصطلحات موضوعية: Cancer Research, All institutes and research themes of the Radboud University Medical Center, Oncology, SDG 3 - Good Health and Well-being, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45482662de6d44c01822ae7e8821564d
https://doi.org/10.1038/s41416-022-02088-8

المؤلفون: Olivier J. van Not, Rik J. Verheijden, Alfonsus J. M. van den Eertwegh, John B. A. G. Haanen, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan-Willem B. de Groot, Geke A. P. Hospers, Anna M. Kamphuis, Ellen Kapiteijn, Anne M. May, Melissa M. de Meza, Djura Piersma, Rozemarijn van Rijn, Marion A. Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Willeke A. M. Blokx, Michel J. M. Wouters, Karijn P. M. Suijkerbuijk

المساهمون: Medical Oncology, Radiology & Nuclear Medicine, Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: JAMA Oncology. AMER MEDICAL ASSOC
JAMA Oncology
JAMA Oncology, 8(12), 1794-1801. American Medical Association
van Not, O J, Verheijden, R J, van den Eertwegh, A J M, Haanen, J B A G, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, de Groot, J-W B, Hospers, G A P, Kamphuis, A M, Kapiteijn, E, May, A M, de Meza, M M, Piersma, D, van Rijn, R, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, Blokx, W A M, Wouters, M J M & Suijkerbuijk, K P M 2022, ' Association of Immune-Related Adverse Event Management with Survival in Patients with Advanced Melanoma ', JAMA Oncology, vol. 8, no. 12, pp. 1794-1801 . https://doi.org/10.1001/jamaoncol.2022.5041
JAMA oncology, 8(12), 1794-1801. AMER MEDICAL ASSOC
Jama Oncology, 8, 12, pp. 1794-1801
Jama Oncology, 8, 1794-1801

مصطلحات موضوعية: Male, Cancer Research, IPILIMUMAB, NIVOLUMAB, Middle Aged, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Cohort Studies, Immune System Diseases, Oncology, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, Humans, FAILURE, Female, Steroids, Melanoma, Immunosuppressive Agents, Retrospective Studies, ANTI-TNF

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b26478643297b0e2ad8b55899ada18a
http://hdl.handle.net/1887/3564012

المؤلفون: Alfonsus J. M. van den Eertwegh, Michel W.J.M. Wouters, Roos S. van Rijn, John B. A. G. Haanen, Maureen J.B. Aarts, Bert-Jan J. ten Tije, Karijn P M Suijkerbuijk, Christian U. Blank, Jesper van Breeschoten, Geke A. P. Hospers, Jan-Willem B de Groot, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Doranne L. Hilarius, Marye J Boers-Sonderen, Djura Piersma, Art Vreugdenhil, Astrid A M van der Veldt, Willeke A. M. Blokx

المساهمون: VU University medical center, Obstetrics and gynaecology, Internal medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Radiology & Nuclear Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: British Journal of Cancer
British Journal of Cancer, 124(7), 1222-1230. Nature Publishing Group
British Journal of Cancer, 124, 7, pp. 1222-1230
British Journal of Cancer, 124, 1222-1230
van Breeschoten, J, Wouters, M W J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, Tije, B-J J T, Veldt, A A M V D, Vreugdenhil, A, Boers-Sonderen, M J & van den Eertwegh, A J M 2021, ' First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis ', British Journal of Cancer, vol. 124, no. 7, pp. 1222-1230 . https://doi.org/10.1038/s41416-020-01229-1
British Journal of Cancer, 124(7), 1222-1230. SPRINGERNATURE

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, PHASE-3, First line, Systemic therapy, VEMURAFENIB, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], POOLED ANALYSIS, Matched cohort, SDG 3 - Good Health and Well-being, Internal medicine, Medicine, METASTATIC MELANOMA, neoplasms, Melanoma, Survival analysis, Advanced melanoma, nivolumab, business.industry, IPILIMUMAB, Anti pd 1, medicine.disease, DABRAFENIB, Propensity score matching, pembrolizumab, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836391be4c5b8d33487fc86cac6f6337
https://doi.org/10.1038/s41416-020-01229-1

المؤلفون: D. Verver, Astrid A M van der Veldt, Jan Willem B. de Groot, Maureen J.B. Aarts, Alfonsus J. M. van den Eertwegh, John B. A. G. Haanen, Karijn P M Suijkerbuijk, Franchette W P J van den Berkmortel, Gerard Vreugdenhil, Djura Piersma, Marye J Boers-Sonderen, Ellen Kapiteijn, Albert J. ten Tije, Dirk J. Grünhagen, Cornelis Verhoef, Geke A. P. Hospers, Rozemarijn S. van Rijn, Alexander C.J. van Akkooi

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Surgery, Medical Oncology, Radiology & Nuclear Medicine

المصدر: Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 70(11), 3123-3135. Springer
Cancer Immunology Immunotherapy, 70, 3123-3135
Verver, D, Grünhagen, D J, van Akkooi, A C J, Aarts, M J B, van den Berkmortel, F W P J, van den Eertwegh, A J M, de Groot, J W B, Boers-Sonderen, M J, Haanen, J B A G, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Tije, A J T, Vreugdenhil, G, Verhoef, C & van der Veldt, A A M 2021, ' Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy ', Cancer Immunology, Immunotherapy, vol. 70, no. 11, pp. 3123-3135 . https://doi.org/10.1007/s00262-021-02871-1
Cancer Immunology Immunotherapy, 70, 3123-3135. SPRINGER
Cancer Immunology, Immunotherapy, 70(11), 3123-3135. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 70, 11, pp. 3123-3135
Cancer Immunology, Immunotherapy, 70(11), 3123-3135. SPRINGER
Cancer Immunology, Immunotherapy, 70(11), 3123-3135. Springer Science+Business Media

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Immunology, Antineoplastic Agents, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Targeted therapy, 03 medical and health sciences, Known primary, 0302 clinical medicine, Interquartile range, Internal medicine, Novel therapy, Immunology and Allergy, Medicine, Humans, Stage IIIC, 030212 general & internal medicine, Molecular Targeted Therapy, Melanoma, Immune Checkpoint Inhibitors, Aged, Performance status, business.industry, Proportional hazards model, Unknown primary, Hazard ratio, Middle Aged, medicine.disease, Confidence interval, 030220 oncology & carcinogenesis, Neoplasms, Unknown Primary, Original Article, Female, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b1ffa47778b2a756d31666f4441d0c
http://europepmc.org/articles/PMC8505371

المؤلفون: Djura Piersma, Marye J Boers-Sonderen, Geke A. P. Hospers, Karijn P M Suijkerbuijk, Christian U. Blank, Roos S. van Rijn, Astrid A M van der Veldt, Jan-Willem B de Groot, Ellen Kapiteijn, Franchette W P J van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jesper van Breeschoten, Doranne L. Hilarius, Bert-Jan J. ten Tije, Michel W.J.M. Wouters, Art Vreugdenhil, John B. A. G. Haanen, Maureen J.B. Aarts, Willeke A. M. Blokx

المصدر: Br J Cancer

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, business.industry, First line, Anti pd 1, Mutant, Correction, Cancer, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, Survival analysis, Advanced melanoma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec07bf292a49af842f52b06a5d9be0e0
https://doi.org/10.1038/s41416-022-01772-z

المؤلفون: Gijs P A, van den Bergh, Malou C P, Kuppen, Hans M, Westgeest, Niven, Mehra, Winald R, Gerritsen, Katja K H, Aben, Inge M, van Oort, Reindert J A, van Moorselaar, Diederik M, Somford, Alfonsus J M, van den Eertwegh, André M, Bergman, Alphonsus C M, van den Bergh, Carin A, Uyl-de Groot

المصدر: Prostate cancer and prostatic diseases.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::b8b26ce75afd4551d282f63653c9ea63
https://pubmed.ncbi.nlm.nih.gov/36224377

المؤلفون: Monique K, van der Kooij, Arjen, Joosse, Karijn P M, Suijkerbuijk, Maureen J B, Aarts, Franchette W P J, van den Berkmortel, Christian U, Blank, Marye J, Boers-Sonderen, Alfonsus J M, van den Eertwegh, Jan Willem B, de Groot, John B A G, Haanen, Geke A P, Hospers, Djura, Piersma, Rozemarijn S, van Rijn, Astrid A M, van der Veldt, Gerard, Vreugdenhil, Hans M, Westgeest, Michel W J M, Wouters, Olaf M, Dekkers, Ellen, Kapiteijn

المصدر: British journal of cancer.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::6f5d2d254816a5181c6493297e5823f8
https://pubmed.ncbi.nlm.nih.gov/36564561

المؤلفون: Gijs P. A. van den Bergh, Malou C. P. Kuppen, Hans M. Westgeest, Niven Mehra, Winald R. Gerritsen, Katja K. H. Aben, Inge M. van Oort, Reindert J. A. van Moorselaar, Diederik M. Somford, Alfonsus J. M. van den Eertwegh, André M. Bergman, Alphonsus C. M. van den Bergh, Carin A. Uyl-de Groot

المساهمون: Urology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, Internal medicine, Medical oncology, CCA - Cancer Treatment and quality of life, Epidemiology and Data Science, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA)

المصدر: Prostate Cancer and Prostatic Diseases. Nature Publishing Group
Prostate Cancer and Prostatic Diseases. SPRINGERNATURE
van den Bergh, G P A, Kuppen, M C P, Westgeest, H M, Mehra, N, Gerritsen, W R, Aben, K K H, van Oort, I M, van Moorselaar, R J A, Somford, D M, van den Eertwegh, A J M, Bergman, A M, van den Bergh, A C M & Uyl-de Groot, C A 2022, ' Incidence and survival of castration-resistant prostate cancer patients with visceral metastases : results from the Dutch CAPRI-registry ', Prostate Cancer and Prostatic Diseases . https://doi.org/10.1038/s41391-022-00605-7
Prostate Cancer and Prostatic Diseases, 26, 162-169
Prostate Cancer and Prostatic Diseases, 26, 1, pp. 162-169
Prostate Cancer and Prostatic Diseases, 26(1), 162-169. Nature Publishing Group

مصطلحات موضوعية: Cancer Research, All institutes and research themes of the Radboud University Medical Center, Oncology, SDG 3 - Good Health and Well-being, Urology, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], MEN, PART, PROGNOSTIC MODEL

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10dc48f47dba4e295a9d0360105b0f15
https://research.vumc.nl/en/publications/ee0eddda-1952-4024-b869-14b80743ad65

المؤلفون: Michel W.J.M. Wouters, Rozemarijn S. van Rijn, Geke A. P. Hospers, Alexander C.J. van Akkooi, Djura Piersma, A Jochems, Jacobus J M van der Hoeven, Marye J Boers-Sonderen, Ellen Kapiteijn, Maureen J.B. Aarts, Astrid A M van der Veldt, Albert J. ten Tije, Franchette W P J van den Berkmortel, Esther Bastiaannet, Karijn P M Suijkerbuijk, Alfonsus J. M. van den Eertwegh, Gerard Vreugdenhil, Michiel C T van Zeijl, Jan Willem B. de Groot, Nienke G de Glas, John B. A. G. Haanen

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Internal medicine, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Oncology, Radiology & Nuclear Medicine

المصدر: Journal of Geriatric Oncology, 12(7), 1031-1038. Elsevier
Journal of Geriatric Oncology, 12, 7, pp. 1031-1038
Jochems, A, Bastiaannet, E, Aarts, M J B, van Akkooi, A C J, van den Berkmortel, F W P J, Boers-Sonderen, M J, van den Eertwegh, A J M, de Glas, N G, de Groot, J W B, Haanen, J B A G, Hospers, G A P, van der Hoeven, J J M, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, van Zeijl, M C T, Kapiteijn, E & Wouters, M W J M 2021, ' Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry ', Journal of Geriatric Oncology, vol. 12, no. 7, pp. 1031-1038 . https://doi.org/10.1016/j.jgo.2021.04.006
Journal of Geriatric Oncology, 12(7), 1031-1038. Elsevier Ltd
Journal of Geriatric Oncology, 12(7), 1031-1038. ELSEVIER SCIENCE BV
Journal of Geriatric Oncology, 12(7), 1031-1038. Elsevier Ltd.
Journal of Geriatric Oncology, 12(7), 1031-1038. ELSEVIER
Journal of Geriatric Oncology, 12, 1031-1038

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, Oncology, medicine.medical_specialty, Skin Neoplasms, MULTICENTER, Ipilimumab, Metastatic melanoma, VEMURAFENIB, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Targeted therapy, 03 medical and health sciences, Immune checkpoint inhibitors, DOUBLE-BLIND, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, AGE, STAGE-III, Internal medicine, medicine, Older patients, Humans, Registries, 030212 general & internal medicine, IMMUNOTHERAPY, Vemurafenib, Melanoma, Aged, Proportional Hazards Models, Outcome, business.industry, Incidence (epidemiology), IPILIMUMAB, Hazard ratio, NIVOLUMAB, Dabrafenib, medicine.disease, DABRAFENIB, 030220 oncology & carcinogenesis, Cohort, Geriatrics and Gerontology, Nivolumab, Safety, business, medicine.drug, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66fbc52a81dd8f88b60e081d0f7c4b28
https://cris.maastrichtuniversity.nl/en/publications/cfd0c268-57aa-4886-9500-888a83898380

المؤلفون: Rutger H. T. Koornstra, Sandrine Marreaud, Victoria Atkinson, Andrey Meshcheryakov, Christian U. Blank, Piotr Rutkowski, Jean-Jacques Grob, Leonel Hernandez-Aya, Clemens Krepler, Michal Kicinski, Dirk Schadendorf, Paolo A. Ascierto, Caroline Robert, Mario Mandalà, Susana Puig, Nageatte Ibrahim, Alexander C.J. van Akkooi, Adnan Khattak, Stéphane Dalle, Georgina V. Long, James Larkin, Shahneen Sandhu, Rahima Jamal, Matteo S. Carlino, Alfonsus J M van den Eertwegh, Ralf Gutzmer, Anna Maria Di Giacomo, Andrew Haydon, Alexander M.M. Eggermont, Stefan Suciu, Paul Lorigan

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology

المصدر: Journal of Clinical Oncology, 38, 3925-3936
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110
Journal of Clinical Oncology, 38(33), 3925-3936. American Society of Clinical Oncology
Journal of Clinical Oncology
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma : Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110
Journal of Clinical Oncology, 38, 33, pp. 3925-3936

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Medizin, Pembrolizumab, Placebo, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Original Reports, medicine, Stage III melanoma, Melanoma, Chemotherapy, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, medicine.disease, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Adjuvant

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c8d8800862ec580f808001677c9a85
https://hdl.handle.net/2066/228545